On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayNov 02, 2020 11:49 am

QualityStocksNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Secures $6.9M in Private Placement

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, earlier this year announced the closing of a private placement financing (the “offering”). According to the update, AzurRx secured approximately $6.9 million in gross proceeds from certain accredited investors, with Alexander Capital LP acting as sole placement agent in the offering. The company intends to use net proceeds to eliminate short- and long-term indebtedness, as well as for general working capital purposes including product development. “We are very grateful for the continued support of our investors,” James Sapirstein, president and CEO of AzurRx said…

Continue Reading

MondayNov 02, 2020 11:32 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Preclinical Study Data Show Drug Combo’s Innovative Potential in Fight Against Major Depressive Disorder

Study results have exciting therapeutic potential across wide range of CNS indications. VTGN focused on developing new generation of medications to treat anxiety, depression and more. Company committed to finding treatment to help estimated 264 million people around the world who suffer from depression. Noting that 17.3 million adults in the United States have had at least one major depressive episode and some 264 million people around the world suffer from depression, VistaGen Therapeutics (NASDAQ: VTGN) is committed to finding effective treatments for depression that reach beyond the current standard of care, which includes oral antidepressants and oral atypical antipsychotics.…

Continue Reading

MondayNov 02, 2020 11:30 am

QualityStocksNewsBreaks – Knightscope Inc. Secures Purchase Order from California Water District

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, recently announced its receipt of a purchase order from a California Water District to help protect the supply of clean/safe water to consumers. The company’s advanced physical security technologies hold significant potential in securing indoor or outdoor operations where a security guard or officer is needed. Knightscope further requested that potential clients and decision makers request a demonstration for the company to showcase how its Autonomous Security Robots (“ASRs”) may help with security needs across the U.S. For more details, visit https://ibn.fm/wmR57…

Continue Reading

MondayNov 02, 2020 11:03 am

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Announces Granting of Stock Options, Appointment of New CEO

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced that, per its stock option plan, it has granted an aggregate of 1,850,000 incentive stock options to directors, officers and advisors of the company. According to the update, the stock options will vest immediately and be exercisable to purchase one common share in the capital of the company on or before November 2, 2025, at a price of $0.42 per share. In addition, GoldHaven announced the appointment of Daniel Schieber as its chief executive officer and a director…

Continue Reading

MondayNov 02, 2020 11:02 am

CNS Pharmaceuticals (NASDAQ: CNSP) Announces Completion of Drug Manufacturing for Brain Cancer Trial

Houston-based CNS Pharmaceuticals is preparing to launch Phase 2 clinical testing of a novel brain cancer-fighting drug candidate called Berubicin early next year The biopharmaceutical company recently announced that a U.S.-based company contracted to make Berubicin has completed its production process and an Italian company working on a dual track in Europe is expected to finish by the end of the year Berubicin has shown promise in combatting Glioblastoma multiforme, an aggressive form of brain cancer commonly regarded as incurable. One participant in Berubicin’s Phase 1 trial remains cancer-free 14 years after the trial CNS Pharmaceuticals, with its sublicensee partner…

Continue Reading

MondayNov 02, 2020 10:29 am

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q3-2020 Results, Notes Significant Strides on Multiple Initiatives

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium in the United States, on Friday reported its financial results for the quarter ended September 30, 2020. In addition, Energy Fuels will host a webcast to review the results at 4:00 p.m. ET on Tuesday, November 3, 2020. Interested parties may join by dialing 1-888-390-0541 (toll free in the U.S. and Canada) and accessing the viewer-controlled webcast slides via the following link: https://ibn.fm/WrPyC. “Energy Fuels made significant strides in the last quarter on our uranium, rare earths and other initiatives,” the company’s president and CEO Mark S. Chalmers…

Continue Reading

MondayNov 02, 2020 10:19 am

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Achieves Debt-Free Milestone, Provides ‘Clean Slate’ for Increased Uranium Production

One of few uranium, natural resource companies in North America with no debt Sets stage for increasing uranium production as markets improve; launching rare earth element initiative Allows rare earth production as markets warrant Applauds U.S. government for securing agreement to limit imports of uranium from Russia Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium mining company in the United States, has officially reached debt-free status, a goal it has been working toward for the past several months (https://ibn.fm/BFes9). The company reached that goal following the retirement of its remaining Cdn$10.4 million of floating rate convertible unsecured subordinated debentures; the…

Continue Reading

MondayNov 02, 2020 9:41 am

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) Secures New, Repeat BolaWrap(R) Orders, Appoints New Director of International Sales

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, announced receipt of new and repeat domestic orders for BolaWrap(R) products and accessories. According to the update, the company has received numerous recent orders from domestic law enforcement agencies and expects to complete shipping next month. In addition, the company today announced the appointment of Jags Gill as its new director of international sales. Based out of London, Gill brings over 15 years of experience in senior sales management across global law enforcement and security sectors. In his new role, Gill will be responsible for managing and driving international sales…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered